Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@genomics-online.com

Casilio® Mammalian Expression Vectors

The Casilio mammalian expression vectors were developed with the Casilio system, an approach that has distinct advantages in multiplexing and multimerization, in comparison to conventional CRISPR/Cas9 usage. Casilio has the unique ability to simultaneously regulate multiple target genes in a cell, providing a more powerful way of studying genes inside living organisms. Discover the flexibility and compatibility of Casilio vectors for gene editing, transcription regulation, and DNA-binding fluorescent protein-based detection.

What is the Casilio System?

Casilio is a hybrid system combining CRISPR/dCas9 and the Pumilio RNA-binding domain (fig.1). The Pumilio/PUF RNA binding domain consists of eight sequence repeats, each capable of recognizing a single RNA base. Within each repeat, specific residues can be altered to facilitate recognition of each of the four RNA bases. In contrast to the conventional approach of directly attaching effector domains to dCas9 in CRISPR/dCas9-based enzymes, effector proteins are repositioned. This was achieved by modifying the sgRNA (sgRNA-PBS), which contains varying numbers of 8-mer Pumilio binding sites (PBS) that can then recruit effector domains fused to cognate PUF domains.

dCas9EffectorPUFCasilioModule
Fig.1: Casilio hybrid system combining CRISPR/dCas9 and Pumilio RNA-binding domain.

What are the Advantages of the Casilio System?

The Casilio system overcomes several downfalls of classic dCas9 vectors. dCas9 fusions cannot be co-introduced with sgRNAs to regulate two set of genes differently since both fusions will bind to both set of genes directed by both sets of sgRNAs. Additionally, often more than one molecule of effector proteins is desired to achieve sufficient biological activity. Existing solutions such as modified sgRNA extended with structural aptamers show inhibitory effects when used in higher numbers. Key advantages of the RNA-aptamer based approach of the Casilio system are:

  • Multiplexing: Different sgRNA-PBS allow simultaneous recruitment of various effectors at different target sites.
  • Flexibility: No need for specific Cas9 fusions proteins depending on the effector; sgRNA-PBS and Casilio-modules vary.
  • Compatibility: No need to change existing work-flows and SOPs.

Casilio modules are orthogonal, allowing simultaneous and independent activation and repression of different genes (Fig. 2). Additionally, Casilio can multiplex and multimerize effectors and potentially enable assembly of stoichiometrically defined protein complexes (Fig. 3).

dCas9E1dCas9E2dCas9E3sgRNA1sgRNA2sgRNA3
Fig.2: Multiplexing Capabilities of the Casilio hybrid system.
dCas9E1E2E4E3sgRNA
Fig.3: Multimerization in the Casilio hybrid system .

This makes the Casilio system an ideal option for transcription regulation, fluorescent protein-based detection as well as gene editing. Explore our available vectors for the Casilio system below.


References

Taghbalout, Du, Jillette, Rosikiewicz, Rath, Heinen, Li, Cheng: "Enhanced CRISPR-based DNA demethylation by Casilio-ME-mediated RNA-guided coupling of methylcytosine oxidation and DNA repair pathways." in: Nature communications, Vol. 10, Issue 1, pp. 4296, (2020) (PubMed).


Casilio® is a registred trademark of the Jackson Laboratory

34 results :

No products found for: Your selected filters.

Unfortunately there are no results for your search

Maybe we can help you with your search:

  • Check our resources results.
  • Contact customer service: (Support)
  • Please check your country setting. This setting determines which products are displayed: United States (Change)
  • Changing search terms and narrowing down your search may lead to more results.
  • Visit our Custom Services section. We offer customized antibody and assay production. (Learn more)

  • Type Plasmid
    • Plasmid
  • Supplier
    • antibodies-online
  • Target
    • SgRNA-5xPBSc
    • dCas9
    • 3xFLAG-4xNLS-PUFc-2xNLS-p65HSF1
    • BFPKRAB-4xNLS-PUFa-2xNLS-3xFLAG
    • BRCA1_53BP1
    • BRCA1_PUFa
    • CRISPR-Cas9
    • Clover_PUF48107
    • Clover_PUFc
    • CtIP(T847E)_53BP1
    • CtIP(T847E)_PUFa
    • FANCF_53BP1
    • FANCF_PUFa
    • HGADD45A-PUFa-hTET1
    • NLS-PUFa-VP64
    • NLS-PUFc-VP64
    • PUF9R_iRFP670
    • PUF9R_mRuby2
    • PUFa-hNEIL2-hTET1
    • PUFa-hTET1
    • PUFa-p65HSF1
    • SgFE-CXCR4-5xPBSa
    • SgFE-EMX1-5xPBSa
    • SgRNA-15xPBS9R
    • SgRNA-15xPBSc
    • SgRNA-20xPBS48107
    • SgRNA-20xPBSc
    • SgRNA-25xPBS9R
    • XRCC3_53BP1
    • XRCC3_PUFa
    • iRFP670_PUFc
    • mCBPHAT-4xNLS-PUFa-2xNLS
  • Reactivity
    • Various Species
  • Application Epigenetic Editing (EpEd)
    • Epigenetic Editing (EpEd)
    • Protein Expression (PExp)
    • Genome Editing with Engineered Nucleases (GEEN)
    • Cloning (Clon)
    • RNA Interference (RNAi)
    • Split-Selectable Marker (SSM)
    • Negative Control (NC)
    • Protein Extraction (PEx)
  • Conjugate
    • Un-conjugated
    • RFP tag
    • BFP
    • GFP tag
  • Vector Backbone
    • lenti_dCas9_Blast
    • pCR8-sgFE-CXCR4-5xPBSa
    • pCR8-sgFE-EMX1-5xPBSa
    • pCR8-sgRNA-15xPBS9R
    • pCR8-sgRNA-15xPBSc
    • pCR8-sgRNA-20xPBS48107
    • pCR8-sgRNA-20xPBSc
    • pCR8-sgRNA-25xPBS9R
    • pLX-CMV_CAG-PUFa-hNEIL2-hTET1
    • pLX-CMV_CAG-PUFa-hTET1
    • pLX-CMV_CAG-PUFa-p65HSF1
    • pLX-CMV_CAG-hGADD45A-PUFa-hTET1
    • pX-SPFE-BbsI-sgRNA-5xPBSa
    • pX-SPFE-BbsI-sgRNA-5xPBSc
    • pmax-3xFLAG-4xNLS-PUFc-2xNLS-p65HSF1
    • pmax-BFPKRAB-4xNLS-PUFa-2xNLS-3xFLAG
    • pmax-BRCA1_53BP1
    • pmax-BRCA1_PUFa
    • pmax-Cas9
    • pmax-Clover_PUF48107
    • pmax-Clover_PUFc
    • pmax-CtIP(T847E)_53BP1
    • pmax-CtIP(T847E)_PUFa
    • pmax-FANCF_53BP1
    • pmax-FANCF_PUFa
    • pmax-NLS-PUFa-VP64
    • pmax-NLS-PUFc-VP64
    • pmax-PUF9R_iRFP670
    • pmax-PUF9R_mRuby2
    • pmax-XRCC3_53BP1
    • pmax-XRCC3_PUFa
    • pmax-dCas
    • pmax-iRFP670_PUFc
    • pmax-mCBPHAT-4xNLS-PUFa-2xNLS
  • Vector
    • Mammalian Expression Vector
    • Lentiviral Vector
  • Insert
    • Casilio Regulation
    • Casilio HDR
    • Casilio Imaging
  • Bacterial Resistance
    • Kanamycin
    • Ampicillin
    • Spectinomycin
  • Expression Type
    • Transient
  • Selectable Marker
    • Puromycin
    • Blasticidin
  • Promoter
    • CMV Promoter
    • T7 Promoter
    • U6 Promoter
    • EFS Promoter
  • Format
    • Liquid
You are here:
Payment Options
Purchase Order
Money-back-Guarantee
Contact

antibodies-online.com
Jones Boulevard 321
19464, Limerick PA
United States

Phone +1 877 302 8632
Fax +1 888 205 9894

Partners

Rockland Immunochemicals, Inc.

© antibodies-online 2024
Support